Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.
about
HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillanceNatural selection of tumor variants in the generation of "tumor escape" phenotypesIdentification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysisNKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysisIdentification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cellsNTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative diseaseTransmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupialGenome wide in silico SNP-tumor association analysisUpdate on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition.The urgent need to recover MHC class I in cancers for effective immunotherapyMHC class I antigen processing and presenting machinery: organization, function, and defects in tumor cellsGenetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on MelanomaThe biological complexity of colorectal cancer: insights into biomarkers for early detection and personalized careTumour immunology, vaccination and escape strategiesIn Vitro Pre-Clinical Validation of Suicide Gene Modified Anti-CD33 Redirected Chimeric Antigen Receptor T-Cells for Acute Myeloid LeukemiaColorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology ApproachDistinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.Distinct functions of the ATP binding cassettes of transporters associated with antigen processing: a mutational analysis of Walker A and B sequences.High resolution human leukocyte antigen (HLA) class I and class II allele typing in Mexican mestizo women with sporadic breast cancer: case-control study.A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against RhabdomyosarcomaCytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.Immunotherapy for pediatric cancer.Immune selection in neoplasia: towards a microevolutionary model of cancer development.Clinical implication of HLA class I expression in breast cancerUpregulation of MICA on high-grade invasive operable breast carcinomaThe tumour suppressor Fhit positively regulates MHC class I expression on cancer cells.CD8 T-cell induction against vascular endothelial growth factor receptor 2 by Salmonella for vaccination purposes against a murine melanomaVaccines in oncology: background and clinical potential.T-cell-directed cancer vaccines: mechanisms of immune escape and immune tolerance.Recognition of tumors by the innate immune system and natural killer cells.MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitroLarge-scale characterization of peptide-MHC binding landscapes with structural simulations.Imaging immune surveillance by T cells and NK cells.Targeting tumours with genetically enhanced T lymphocytes.Principles of tumor immunosurveillance and implications for immunotherapy.Relationship between the downregulation of HLA class I antigen and clinicopathological significance in gastric cancer.Therapeutic vaccination with tumor cells that engage CD137.False homozygosity results in HLA genotyping due to loss of chromosome 6 in a patient with acute lymphoblastic leukemia.Treating cancer with genetically engineered T cells.Transporter associated protein expression in uveal melanoma.
P2860
Q24323589-38F80557-FA90-424B-A32F-5FCC60869CDCQ24551158-5CD90DD3-457F-4B55-AAC9-90631E09EDD0Q24562910-9F1ACA60-DAD2-47DB-9B13-382660012CC7Q24647094-021D5EEC-440C-4D7C-9883-85282CF904D2Q24671834-8E052101-1C5C-403A-AF74-FE4C3A8CA081Q24675566-1E1C6A5A-647F-40CA-8FE6-A9E1F7D9B31CQ24679604-110741B9-9668-4179-B790-E0576A4B3DCEQ24797244-26976524-9BBF-4E29-97BF-70E2DB09A436Q24801995-2899D0C3-6A0C-48A4-AA15-0758695CF7D0Q26770165-3B214956-DAB3-49D0-A39C-B99D41D93887Q26866479-9AB71BE8-189E-43FC-8AFD-0C07D6EFA361Q27346600-6C1F6784-8720-46CC-8EC1-D3F178763E95Q28066460-48092714-2983-48EA-8960-7E3D434E42C8Q28208633-31090F7F-CA9E-4BD9-9758-BAEBA6A6D4FEQ28554677-84287E67-DCB0-44F1-ABDB-A1545469B171Q28647615-A8FC282F-8F46-4322-856C-72DF615127D2Q30830061-096E21D5-351B-4A45-BCB7-89F9CCB6BEC4Q33181866-B2D8535C-DECF-4FBB-9357-197AA47DF347Q33406039-56092687-F248-406C-8278-29282D091FF3Q33785788-E0189335-13F3-4747-A3A3-2A0D787A6542Q33815865-3870C53D-DF37-4D4A-BABC-50519E607D3AQ33924586-5CE5A544-F85D-46F0-8E50-B9338A7F1EB4Q33948688-15C7B701-07EE-45A9-BDBA-1A282AEE9CE2Q34052449-EC383005-C902-4135-AD63-AC8453C495D6Q34111707-7B99EA53-74A1-4EC1-BAB3-207F4B20F548Q34208784-844C2FDE-D527-40FC-B2FE-781007D679F1Q34236740-64B5A025-3E3E-4769-AFAB-906156E46DD9Q34439914-18AA261A-D702-494B-9667-330B865E7542Q34452013-0B27C467-6FBF-4473-A76D-1AC92B933E11Q34496462-6B0D9F49-F33B-43C5-A717-77267F479D05Q34615021-84984C70-0907-4212-9630-C3A56BAE517AQ34880483-7992E42C-82FE-44AA-A920-8A75C21A06E3Q35005898-380DB2A0-A18A-43E0-A562-555A1DB18150Q35037678-FA92E257-CD05-4F54-B86D-36B31414ED11Q35043113-E89C6AA1-A319-4BC5-B73A-B3FA72F33B45Q35045298-78585C92-5F39-418B-AC0A-14847869C029Q35071688-FFB2FB10-6977-44D9-A190-4B78B54B19ADQ35300418-447F22F8-75D3-447F-994E-D0B6786A75ADQ35353365-067C3EE7-82CF-4C0A-936A-61781568AD13Q35592247-BA41F1BE-C843-4960-8799-A839381D0DD0
P2860
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.
@en
type
label
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.
@en
prefLabel
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.
@en
P2093
P1433
P1476
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.
@en
P2093
Duggan-Keen M
López-Botet M
Pérez-Villar JJ
Ruiz-Cabello F
P356
10.1016/S0167-5699(96)10075-X
P577
1997-02-01T00:00:00Z